Plum SEC
  • Korean Market
  • Privacy Policy

Korean Market

  • Reset (View All)

  • ★★★★★
  • ★★★★
  • ★★★
  • ★★
  • ★

  • ★

  • ★
  • ★★
  • ★★★
  • ★★★★
  • ★★★★★
All Disclosures
OWNR
DongKoo Bio & Pharma
★

DongKoo Bio & Pharma's Major Shareholder Yongjun Jo Reduces Pledged Shares by 49,261 Due to Partial Loan Repayment... Slight Improvement in Financial Stability

  05/26/2026, 04:23 PM
PERI
DongKoo Bio & Pharma
★

Dongkoo Bio&Pharma Q1 2026 Operating Profit of KRW 1.8B… Net Loss and Higher Debt Ratio

  05/15/2026, 02:15 PM
OWNR
DongKoo Bio & Pharma
★

Submission of Large Shareholding Report (General, No Material Changes)

  05/13/2026, 03:56 PM
한국어 | English | 中文 | 日本語
Plum SEC © 2026.05.25
The information provided on this site is for reference only and we do not guarantee its accuracy or completeness. Users are solely responsible for any investment decisions made based on this information.